This has to be one of the small cap best biotech I came across in ASX. Meeting all the target on time, solid revenue base with significant upside potential, paying dividends. A bit more liquidity would have been better but other than that not sure what more can I ask for....
- Forums
- ASX - By Stock
- CYC
- Ann: 40 Patient Milestone Achieved For Technegas USFDA Trial
CYC
cyclopharm limited
Add to My Watchlist
2.94%
!
52.5¢
Ann: 40 Patient Milestone Achieved For Technegas USFDA Trial, page-3
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
